These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32822662)
1. Assessment of mass spectrometry-based pain management testing in clinical laboratories across North America. Delaney SR; Danso D; Langman LJ; Jannetto PJ Clin Biochem; 2020 Nov; 85():49-52. PubMed ID: 32822662 [TBL] [Abstract][Full Text] [Related]
2. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management. Reisfield GM; Goldberger BA; Bertholf RL J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Manchikanti L; Malla Y; Wargo BW; Fellows B Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372 [TBL] [Abstract][Full Text] [Related]
5. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473 [TBL] [Abstract][Full Text] [Related]
6. Urine drug testing for pain management. Magnani B; Kwong T Clin Lab Med; 2012 Sep; 32(3):379-90. PubMed ID: 22939297 [TBL] [Abstract][Full Text] [Related]
7. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test? Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816 [TBL] [Abstract][Full Text] [Related]
8. Urine drug testing in chronic pain. Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368 [TBL] [Abstract][Full Text] [Related]
9. Rational use and interpretation of urine drug testing in chronic opioid therapy. Reisfield GM; Salazar E; Bertholf RL Ann Clin Lab Sci; 2007; 37(4):301-14. PubMed ID: 18000286 [TBL] [Abstract][Full Text] [Related]
10. Urine and oral fluid drug testing in support of pain management. Kwong TC; Magnani B; Moore C Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451 [TBL] [Abstract][Full Text] [Related]
11. Analysis of codeine positivity in urine of pain management patients. Colby JM; Wu AH; Lynch KL J Anal Toxicol; 2015 Jun; 39(5):407-10. PubMed ID: 25840440 [TBL] [Abstract][Full Text] [Related]
14. Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects. Lee CT; Vo TT; Cohen AS; Ahmed S; Zhang Y; Mao J; Chen L Pain Med; 2016 Apr; 17(4):636-43. PubMed ID: 26398237 [TBL] [Abstract][Full Text] [Related]
15. Role of urine toxicology testing in the management of chronic opioid therapy. Katz N; Fanciullo GJ Clin J Pain; 2002; 18(4 Suppl):S76-82. PubMed ID: 12479257 [TBL] [Abstract][Full Text] [Related]
16. Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain. Koyyalagunta D; Bruera E; Engle MP; Driver L; Dong W; Demaree C; Novy DM Pain Med; 2018 Jul; 19(7):1469-1477. PubMed ID: 29016951 [TBL] [Abstract][Full Text] [Related]
17. Urine drug testing: current recommendations and best practices. Owen GT; Burton AW; Schade CM; Passik S Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451 [TBL] [Abstract][Full Text] [Related]
18. Urine Drug Testing in Cancer Pain Management. Arthur JA Oncologist; 2020 Feb; 25(2):99-104. PubMed ID: 32043770 [TBL] [Abstract][Full Text] [Related]